olivLaw · US equity research
AXIL Brands, Inc. AXIL
Perfumes, Cosmetics & Other Toilet Preparations · SIC 2844 · Vertical: Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844)
AXIL Brands sells hearing enhancement and protection products and professional hair and skin care products through direct-to-consumer channels and retail networks. Revenue reached 30,847,570 USD in fiscal 2026, and the XCOR II launch in the first quarter of fiscal 2027 produced orders above 3.6 million USD, which makes the company relevant to investors watching its shift toward retail.
At the close of 04 Nov 2026, AXIL Brands, Inc. (AXIL) stock was 5.60 USD (−2.78% on the day), with market capitalisation 38.2 m USD, P/E 16.7 on diluted EPS of 0.34 USD over the last 12 months, beta 0.55, 52-week range 4.75–8.69 USD. Latest reported quarter (Q1 2027): revenue of 6.1 m USD (−11.2% YoY), net income of 420.6 k USD (+25.8% YoY), diluted EPS 0.05 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 46.0
- neutral
- Bollinger (20, 2)
- 5.35 – 5.92
- in the lower half of the band · %B 0.44 · band width 10.1%
- SMA 50 / 200
- 5.98 / 6.38
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.09 / -0.11
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −8.0% | −1.1% | −6.9 pp | — |
| 3 months | −3.8% | −0.5% | −3.3 pp | — |
| 6 months | −17.4% | +4.4% | −21.8 pp | — |
| Year to date | −19.2% | +12.3% | −31.5 pp | — |
| 1 year | +11.8% | +13.5% | −1.8 pp | +4.5% |
| 3 years | unavailable | +76.4% | unavailable | −13.5% |
| 5 years | unavailable | +63.7% | unavailable | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q1 2027 · 31 Aug 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.7 m | 6.9 m | 5.8 m | 6.9 m | 8.1 m | 7.3 m | 8.6 m | 6.1 m |
| Cost of revenue | 2.2 m | 2.0 m | 1.7 m | 2.2 m | 2.6 m | 2.3 m | 2.3 m | 1.0 m |
| Gross profit | 5.5 m | 5.0 m | 4.0 m | 4.6 m | 5.5 m | 5.0 m | 6.2 m | 5.0 m |
| Operating income | 672.9 k | 583.1 k | 46.1 k | 411.7 k | 903.1 k | 214.2 k | 1.4 m | 437.0 k |
| Depreciation & amortisation | 34.4 k | 45.7 k | 55.5 k | 62.1 k | 67.5 k ≈ | 54.4 k ≈ | 62.8 k | 65.5 k |
| Interest expense | 1.3 k | 1.3 k | 1.3 k | 1.3 k | 1.3 k | 1.4 k | -1.4 k | — |
| Pre-tax income | 701.0 k | 629.7 k | 87.9 k | 449.4 k | 938.0 k | 267.4 k | 1.5 m | 520.2 k |
| Income tax | 67.3 k | 53.1 k | 333.5 k | 115.1 k | 233.1 k | 64.3 k | 27.8 k | 99.6 k |
| Net income | 633.7 k | 576.7 k | -245.6 k | 334.3 k | 704.9 k | 203.0 k | 1.5 m | 420.6 k |
| Diluted EPS | 0.08 | 0.07 | -0.03 ≈ | 0.04 | 0.09 | 0.02 | 0.18 ≈ | 0.05 |
| Operating cash flow | 1.0 m ≈ | -169.9 k ≈ | 194.4 k | -739.2 k | 934.8 k ≈ | 594.7 k ≈ | -800.0 k | 3.8 m |
| Capex | 65.8 k | 148.2 k | 59.4 k | 8.4 k | 28.4 k ≈ | 41.9 k ≈ | 679 | 55.3 k |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 0 percentile of its own 11-quarter history (min 19.8, median 56.5, max 92.0; quarters with earnings only).
Fiscal years
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 992.7 k | 1.0 m | 1.6 m | 2.3 m | 23.5 m | 27.5 m | 26.3 m | 30.8 m |
| Revenue YoY | +6.4% | +2.0% | +61.3% | +43.0% | +906.8% | +16.9% | −4.5% | +17.5% |
| Net income | -150.0 k | -172.8 k | -297.8 k | -182.9 k | 1.8 m | 2.0 m | 855.0 k | 2.7 m |
| Net income YoY | unavailable | unavailable | unavailable | unavailable | unavailable | +9.8% | −57.3% | +215.7% |
| Diluted EPS | unavailable | unavailable | unavailable | 0.00 | 0.10 | 0.21 | 0.10 | 0.33 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | unavailable | +110.0% | −52.4% | +230.0% |
| net % | -15.1% | -17.1% | -18.2% | -7.8% | 7.8% | 7.3% | 3.3% | 8.8% |
| Free cash flow | -188.9 k | -98.9 k | 33.0 k | unavailable | 2.9 m | -135.8 k | 1.7 m | -89.0 k |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2026 · 31 May 2026
- Cash
- 4.5 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- 13.1 m USD
- Total assets
- 18.0 m USD
- Debt / equity
- unavailable
- Current ratio
- 3.19x
- ROE
- 23.7%
- ROA
- 17.5%
- FCF margin
- -0.3%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 1.6 m | 2.3 m | 23.5 m | 27.5 m | 26.3 m | 30.8 m | SEC (XBRL)· 18 Aug 2026verified |
| Cost of revenue | 599.7 k | 828.6 k | 5.8 m | 7.3 m | 7.6 m | 9.4 m | SEC (XBRL)· 18 Aug 2026verified |
| Gross profit | 1.0 m | 1.5 m | 17.7 m | 20.2 m | 18.6 m | 21.4 m | SEC (XBRL)· 18 Aug 2026verified |
| Operating income | -321.1 k | -211.4 k | 2.0 m | 1.5 m | 1.2 m | 3.0 m | SEC (XBRL)· 18 Aug 2026verified |
| Depreciation & amortisation | — | 7.9 k | 95.2 k | 130.6 k | 148.5 k | 246.7 k | SEC (XBRL)· 18 Aug 2026verified |
| EBITDA | — | -203.5 k ≈ | 2.1 m ≈ | 1.6 m ≈ | 1.3 m ≈ | 3.2 m ≈ | SEC (XBRL)· 18 Aug 2026derived |
| Interest expense | 6.1 k | 6.5 k | 2.5 k | 4.4 k | 3.9 k | 2.6 k | SEC (XBRL)· 18 Aug 2026verified |
| Pre-tax income | -297.8 k | -182.9 k | 2.1 m | 1.8 m | 1.3 m | 3.1 m | SEC (XBRL)· 18 Aug 2026verified |
| Income tax | — | — | 230.9 k | -220.2 k | 453.8 k | 440.3 k | SEC (XBRL)· 18 Aug 2026verified |
| Net income | -297.8 k | -182.9 k | 1.8 m | 2.0 m | 855.0 k | 2.7 m | SEC (XBRL)· 18 Aug 2026verified |
| Diluted EPS | — | 0.00 | 0.10 | 0.21 | 0.10 | 0.33 | SEC (XBRL)· 18 Aug 2026verified |
| Weighted average diluted shares | — | 41.9 m | 17.9 m | 16.2 m | 8.2 m | 8.3 m | SEC (XBRL)· 18 Aug 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 496.9 k | 373.7 k | 4.8 m | 3.3 m | 4.8 m | 4.5 m | SEC (XBRL)· 18 Aug 2026verified |
| Inventories | 490.9 k | 323.4 k | 1.3 m | 3.4 m | 2.5 m | 4.4 m | SEC (XBRL)· 18 Aug 2026verified |
| Current assets | 1.0 m | 803.0 k | 7.4 m | 8.0 m | 9.3 m | 14.3 m | SEC (XBRL)· 18 Aug 2026verified |
| Property, plant & equipment, net | 37.0 k | 29.1 k | 157.5 k | 260.9 k | 412.3 k | 389.7 k | SEC (XBRL)· 18 Aug 2026verified |
| Goodwill | — | — | 2.2 m | 2.2 m | 2.2 m | 2.2 m | SEC (XBRL)· 18 Aug 2026verified |
| Intangibles (excl. goodwill) | — | — | 382.7 k | 309.1 k | 403.6 k | 389.7 k | SEC (XBRL)· 18 Aug 2026verified |
| Total assets | 1.3 m | 893.9 k | 10.2 m | 11.0 m | 12.9 m | 18.0 m | SEC (XBRL)· 18 Aug 2026verified |
| Accounts payable | 459.0 k | 458.3 k | 908.6 k | 967.6 k | 866.6 k | 2.0 m | SEC (XBRL)· 18 Aug 2026verified |
| Long-term debt | — | — | 172.6 k | 146.6 k | 140.2 k | — | SEC (XBRL)· 21 Aug 2025verified |
| Current liabilities | 712.4 k | 707.0 k | 2.9 m | 2.8 m | 2.5 m | 4.5 m | SEC (XBRL)· 18 Aug 2026verified |
| Total liabilities | 917.1 k | 709.2 k | 3.5 m | 3.3 m | 3.2 m | 4.8 m | SEC (XBRL)· 18 Aug 2026verified |
| Equity | 345.6 k † | 184.7 k † | 6.7 m † | 7.7 m † | 9.7 m | 13.1 m | SEC (XBRL)· 06 Oct 2026verified |
| Shares outstanding at year end | 41.9 m | — | — | — | — | — | SEC (XBRL)· 30 Aug 2021verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 48.4 k | -126.1 k | 2.9 m | 2.7 k | 1.9 m | -9.6 k | SEC (XBRL)· 18 Aug 2026verified |
| Capex | 15.4 k | — | 65.7 k | 138.4 k | 213.5 k | 79.4 k | SEC (XBRL)· 18 Aug 2026verified |
| Free cash flow | 33.0 k ≈ | — | 2.9 m ≈ | -135.8 k ≈ | 1.7 m ≈ | -89.0 k ≈ | SEC (XBRL)· 18 Aug 2026derived |
| Investing cash flow | -15.4 k | — | 1.0 m | -160.5 k | -394.3 k | -210.3 k | SEC (XBRL)· 18 Aug 2026verified |
| Financing cash flow | 54.9 k | 2.8 k | 540.1 k | -1.4 m | -18.4 k | -87.8 k | SEC (XBRL)· 18 Aug 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 58.3% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 38.2 m USD
Key indicators
Coverage and freshness
Score by group
58% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 4.29 – 7.82 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/E4.29 – 7.82 (Mid 7.35)5 companies used · median multiple 21.9x · quartiles 12.8x – 23.3xCL, IPAR, KVUE, ODD, UG
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 58.3% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 9.3% | 60 (vs peers) | 11% |
| FCF conversion · Quality | 156.7% | 100 (on a fixed band) | 11% |
| Revenue CAGR 3Y · Growth | 9.5% | 79 (on a fixed band) | 14% |
| EPS CAGR 3Y · Growth | 48.9% | 100 (on a fixed band) | 14% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 1,160.5x | 100 (on a fixed band) | 11% |
| Current ratio · Balance sheet | 3.3x | 100 (on a fixed band) | 7% |
| P/E (TTM) · Valuation | 16.7x | 71 (vs peers) | 18% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 11.4% | 100 (on a fixed band) | 14% |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet100/100 · 2/3 factors with a value
- Growth89/100 · 2/2 factors with a value
- Quality80/100 · 2/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation84/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
AXIL BRANDS, INC. (AXIL). Latest full fiscal year: 2026; data up to 2026-08-31.
Figures computed from the financial statements: revenue 30.8 m USD in 2026; YoY growth 17.5%; net margin 9.3%; ROE 23.3%.
The estimated value range is 4.29–7.82 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 7.35 USD, the price of 5.60 USD leaves a potential of 31.3% (value / price − 1) and a margin of safety of 23.8% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 58.3% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- FCF conversion: 156.7%
- Revenue CAGR 3Y: 9.5%
- EPS CAGR 3Y: 48.9%
- Interest coverage: 1,160.5x
- Current ratio: 3.3x
- P/E (TTM): 16.7x
- FCF yield: 11.4%
What contradicts it
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
Not assessed (insufficient data or a ratio without meaning): ROIC, Net debt / EBITDA, EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Perfumes, Cosmetics & Other Toilet Preparations (SIC 2844) · same industry (4-digit SIC) · compared with 15 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| CLColgate-Palmolive Company | 78.5 bn | 38.7 | 358.9% | 9.6% | +1.4% | +23% / +25% |
| KVUEKenvue Inc. | 37.1 bn | 21.9 | 16.3% | 10.9% | −2.1% | +34% / +4% |
| ELFe.l.f. Beauty, Inc. | 6.7 bn | 113.6 | 6.0% | 3.4% | +24.6% | +49% / −4% |
| IPARInterparfums, Inc. | 4.0 bn | 23.3 | 19.5% | 11.3% | +2.5% | +52% / −1% |
| COTYCoty Inc. | 3.1 bn | — | -18.5% | -10.4% | −1.5% | +5% / −70% |
| EPCEdgewell Personal Care Company | 1.4 bn | — | -6.2% | -4.2% | −1.3% | +66% / −15% |
| SLSNSolesence, Inc. | 64.6 m | — | -15.1% | -3.8% | +18.6% | −60% / +22% |
| AXILAxil Brands, Inc. | 38.2 m | 16.7 | 23.3% | 9.3% | +17.5% | +12% / unavailable |
| UGUnited-Guardian, Inc. | 31.5 m | 12.8 | 21.4% | 22.0% | −13.4% | +18% / −16% |
| CABRCaring Brands, Inc. | 9.3 m | — | -3,889.1% | -183,298.7% | unavailable | −13% / unavailable |
| BNKKBonk, Inc. | 9.3 m | — | -332.4% | -2,330.4% | +201.6% | −82% / −99% |
| YCBDcbdMD, Inc. | 4.5 m | — | -40.3% | -13.8% | −1.5% | −34% / −93% |
| HLNHaleon plc | — | — | 10.2% | 15.1% | −1.8% | −6% / +8% |
| ODDOddity Tech Ltd | — | 12.0 | 32.6% | 13.7% | +25.2% | −50% / −37% |
| ELEstee Lauder Companies Inc | — | 111.7 | 9.3% | 2.4% | +5.0% | +19% / −12% |
| YSGYatsen Holding Limited | — | — | -2.7% | -1.9% | +32.2% | −67% / −49% |
1- and 3-year price returns: for AXIL from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 4.23 Total return -25% · Per year -25% | 7.45 Total return 33% · Per year 33% | 11.20 Total return 100% · Per year 100% |
| 3 years | 4.52 Total return -19% · Per year -7% | 8.93 Total return 59% · Per year 17% | 14.68 Total return 162% · Per year 38% |
| 5 years | 4.84 Total return -14% · Per year -3% | 10.70 Total return 91% · Per year 14% | 19.23 Total return 243% · Per year 28% |
- Exit P/E± 2.23
- Net margin± 1.56
- Annual revenue growth± 1.22
- Annual dilution± 0.13
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
In brief
AXIL Brands sells hearing enhancement and protection products and professional hair and skin care products through direct-to-consumer channels and retail networks. Revenue reached 30,847,570 USD in fiscal 2026, and the XCOR II launch in the first quarter of fiscal 2027 produced orders above 3.6 million USD, which makes the company relevant to investors watching its shift toward retail.
SWOT
Strengths
- AXIL brand recognition in hearing protection headphones, no debt and good liquidity after the customs refunds were collected.
- An innovative product range with Bluetooth models and proprietary technology, backed by patents and registered trademarks.
- Access to several channels, from direct sales to big-box retail and military networks, which reduces dependence on one channel.
Weaknesses
- Revenue is concentrated in a small number of customers and in one main supplier for the core segment.
- Lower retail channel margins compress gross profitability, and launch costs weighed on the first quarter.
- A very small team, so the departure of key people could have an outsized effect on operations.
Opportunities
- Expansion into military stores and specialised retail could open new customer groups.
- The success of XCOR II could support sales in coming quarters if orders turn into steady demand.
- The Reviv3 relaunch and international partnerships could bring revenue from new markets.
Threats
- New tariffs and changes in trade policy could raise import costs and reduce margins.
- Competitors with larger financial resources and wider distribution could reduce the company's market share.
- Product recalls or non-compliance with safety rules could damage the company's reputation.
Risks
- Customer concentrationhigh
One customer accounted for a major part of revenue and receivables, so losing it could seriously affect results 1.
- Supplier dependencehigh
A small number of suppliers produce key components and raw materials, and a disruption could delay deliveries 1.
- Tariffs and trade policymedium
Changes in tariffs could raise import costs, and the refunds received are not recurring 12.
- Need for additional capitalmedium
If further funding is not available on acceptable terms, growth could be delayed, and new share issues could dilute existing shareholders 1.
- Cybersecuritylow
A security incident or an IT system failure could disrupt operations and expose the company to sanctions 1.
Investment thesis
What would need to be true (bull case)
- If the XCOR II launch turns into repeat sales and retail expansion continues, revenue could grow faster than in fiscal 2026 13.
- The company has good liquidity and no debt, which gives it flexibility to invest in marketing and products 3.
- The Reviv3 partnership and relaunch could bring new revenue without using AXIL cash 23.
What would break the thesis
- Revenue in the first quarter of fiscal 2027 fell, and last year's growth relied on large orders that do not repeat automatically 3.
- Dependence on a few large customers and on one main supplier could make results volatile from quarter to quarter 1.
- Margins could be compressed by the retail channel and new tariffs, and the customs refunds should not be treated as recurring 12.
What to watch
- Level of XCOR II orders and their conversion into salessecond quarter of fiscal 2027
- Gross margin trend excluding the customs refund effectnext quarterly report
- Market reaction to the Reviv3 brand relaunch in September 2026second quarter of fiscal 2027
- Impact of Section 301 tariffs on costsnext annual report
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
The business
AXIL manufactures, markets and distributes hearing enhancement and protection products, professional hair and skin care products and marketing services. The company changed its name from Reviv3 Procare to AXIL Brands in February 2024, with the NYSE American uplisting, and operates through subsidiaries including AXIL Distribution Company, Reviv3 ProCare Company and Sharper Vision Marketing Inc. It had 13 full-time and 2 part-time employees, all in the United States 1. Its headquarters is in Beverly Hills, California 1.
The revenue mix shifted in fiscal 2026 as the retail and wholesale channel grew, and its margins are lower than those of direct sales 1. Customer and supplier concentration is high: one customer accounted for 23% of consolidated revenue and one vendor for 79% of hearing segment purchases 1.
Segments
Hearing enhancement and protection
The main segment, about 96% of fiscal 2026 revenue. It includes Bluetooth earmuffs, earplugs, protective earmuffs and outdoor speakers sold to sporting, tactical, industrial and law enforcement users 1.
Hair and skin care
The Reviv3 Procare segment, about 4% of fiscal 2026 revenue. Products are made by third-party co-packers and sold through e-commerce, distributors and salon partnerships 1. Sales declined in fiscal 2026 because advertising was reduced ahead of a brand relaunch scheduled for September 2026 1.
Marketing services
A small segment that offers performance marketing services to third-party clients through Sharper Vision Marketing. It generated less than 1% of revenue in fiscal 2026 1.
Market context
The global hair care market was estimated at about 82.5 billion USD in 2026, with a growth rate of roughly 5.7% a year towards 108.6 billion USD in 2031, according to a forecast cited by the company 1. The hearing protection market benefits from greater awareness of hearing loss, and the company cites CDC data that 53% of noise-exposed workers do not wear protection 1.
The hearing protection market sits between consumer electronics and protective equipment, so demand depends on both consumer trends and access to retail channels. If the shift to retail continues, revenue could depend less on online advertising 1.
Trends
- Retail expansionmixed
Agreements with Walmart, Sportsman's Warehouse and MCX stores open access to a broader public but also increase dependence on a few large customers 13.
- XCOR II launchtailwind
The new earbud model generated orders above 3.6 million USD through 30 September 2026 and could become a sales driver in coming quarters 23.
- Tariffsheadwind
Tariffs imposed after the February 2026 Supreme Court decision and the new Section 301 rates could raise the cost of imported goods and compress margins 12.
- Reviv3 brand relaunchmixed
The relaunch of the hair care brand and the partnership with three strategic partners, who received 25% of Reviv3, could support segment growth if results follow 123.
Competitive position
In hearing products AXIL competes with ISOtunes, Walker's, SureFire and Sordin, companies with more diversified lines, established distribution and larger financial resources 1. In hair care the competitors are Keranique, Zenagen and Revita 1.
The company cites brand recognition, product technology and innovation, quality and price, and patent protection as its advantages. It holds three active US patents and one pending application 1.
- ISOtunes
Competitor in hearing protection and enhancement headphones, named by the company among its main rivals.
- Walker's
Maker of hearing protection equipment, cited as a direct rival in the sporting and hunting segment.
- SureFire
Company specialised in tactical equipment, present in hearing protection for law enforcement.
- Keranique
Hair care brand, named as a rival in scalp health products.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Proxy statement22 Oct 2026
- Current report06 Oct 2026Results of operations · Financial statements and exhibits
- Quarterly report06 Oct 2026
- Current report18 Aug 2026Results of operations · Financial statements and exhibits
- Annual report18 Aug 2026
- Current report08 Apr 2026Results of operations · Financial statements and exhibits
- Quarterly report08 Apr 2026
- Current report20 Jan 2026Departure or appointment of officers
- Current report08 Jan 2026Results of operations · Financial statements and exhibits
- Quarterly report08 Jan 2026
Sources
- [1] Form 10-K, fiscal year ended 2026-05-31 · SEC / AXIL Brands, Inc. · 18 Aug 2026
- [2] Form 10-Q, quarter ended 2026-08-31 · SEC / AXIL Brands, Inc. · 06 Oct 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / AXIL Brands, Inc. · 06 Oct 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.